Ambient Marketing Fomentil 2019
The Ambient Marketing Fomentil has begun in Turin, Milan e Pavia.
The activity involved the use of a highly scenic booth in which were vaporized the balsamic essences of Fomentil.
SIT PHARMA is pleased to announce the acquisition of OSTIDIL-D3 and KEFORAL
SIT Pharma is pleased to announce the acquisition of DERINOX® from Therabel Lucien Pharma Sas
SIT Pharma is pleased to announce the acquisition of MIZOLLEN® from THERABEL HEALTHCARE LIMITED